International Health Regulations and COVID-19 pandemic, challenges and gaps

Supplementary Files

Figure 1


HR 2005
Global Health

How to Cite

Tabbaa, D. (2020). International Health Regulations and COVID-19 pandemic, challenges and gaps. Veterinaria Italiana, 56(4), 237-244.


International Health Regulations 2005 contributed to the development of public health emergency control programs of international concern. The aim of their application was to mitigate the effects of the spread of such emergencies by proactive measures, stemming from risk assessment and expanding to epidemiological modeling systems that allow a logical extrapolation of what these emergencies can cause, and develop codified international strategies to avoid the occurrence of public health emergencies of international concern as soon as they are early discovered. The COVID‑19 pandemic came to be a model in which these regulations were tested in the biggest challenge that human societies have faced since the Second World War. The implementation of these IHR 2005 had a great positive role in limiting the spread of the disease, but some gaps, that could have been overcome and mitigate its consequences, appeared during the application of the precautionary economic, social and health quarantine systems. This study examines the importance of IHR 2005 and the main challenges it faced in general, focusing on the results of their application in the area of the COVID‑19 pandemic and the gaps that have emerged in the technical, educational and political field and proposals to address them.


Baker M.G. & Fidler D.P. 2006. Global Public Health Surveillance under New International Health Regulations. Emerg Infect Dis, 12 (7), 1058‑1065. doi:10.3201/eid1207.051497.

Benecke O. & DeYoung S.E. 2019. Anti‑vaccine decision‑making and measles resurgence in the United States. Glob Pediatr Health, 6.

Biezen R., Grando D., Mazza D. & Brijnath B. 2019. Visibility and transmission: complexities around promoting hand hygiene in young children‑a qualitative review. BMC Public Health, 19, 398.

Faas A.J. & Barriosv R.E. 2015. Applied anthropology of risk, hazards and disasters. Human Organization, 74, 287‑295.

Forster P., Forster L., Renfrew C. & Forster M. 2020. Phylogenetic network analysis of SARS‑CoV‑2 genomes. PNAS, 117 (17), 9241‑9243.

Gesesew H.A., Tebeje B., Alemseged F. & Beyene W. 2016. Health workforce acquisition, retention and turnover in southwest Ethiopian health institutions. Ethiop J Health Sci, 26, 331‑340.

Global Preparedness Monitoring Board. 2019. Annual report on global preparedness for health emergencies. Geneva, WHO. (accessed on Jan 25, 2020).

Gostin L.O. & Friedman E.A. 2015. A retrospective and prospective analysis of the West African Ebola virus disease epidemic: robust national health systems at the foundation and an empowered WHO at the apex. Lancet, 385, 1902‑1909.‑6736(15)60644‑4/fulltext (accessed on May 27, 2015).

Huang C. & Wang Y Li X. 2019. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497‑506.

Kandel N., Chungong S. & Mahjour J. 2005. Improvement in annual reporting of self‑assessments to the IHR. In Weekly epidemiological record. Geneva, WHO, May 24, 2019.‑iii‑vii‑eng‑fre. pdf (accessed on Jan 26, 2020).

Kandel N., Sreedharan R., Chungong S., Sliter K., Nikkari S., Ijaz K. & Rodier G. Rm. 2017. Joint external evaluation process: bringing multiple sectors together for global health security. Lancet Glob Health, 5, e857‑58.

Kandel N. 2015. Is there a business continuity plan for emergencies like an Ebola outbreak or other pandemics? J Bus Contin Emer Plan, 8, 295‑298.

Lim S.S., Updike R.L., Kaldjian A.S., Barber R.M., Cowling K., York H., Friedman J., Xu R., Whisnant J.L., Taylor H.J., Leever A.T., Roman Y., Bryant M.F., Dieleman J., Gakidou E. & Murray C.J.L. 2018. Measuring human capital: a systematic analysis of 195 countries and territories, 1990‑2016. Lancet, 392, 1217‑1234.

Montgomery J.M., Woolverton A., Hedges S., Pitts D., Alexander J., Ijaz K., Angulo F., Dowell D., Katz R. & Henaoet O. 2019. Ten years of global disease detection and counting: program accomplishments and lessons learned in building global health security. BMC Public Health, 19, 510.

Perlman S. 2020. Another decade, another coronavirus. N Engl J Med, 382, 760‑762.

Richman D.D., Whitley R.J. & Hayden F.G. 2016. Clinical virology, 4th edn. Washington, ASM Press.

Semenza J.C., Sewe M.O., Lindgren E., Brusin S., Kaasik Aaslav K., Mollet T. & Rocklöv J. 2019. Systemic resilience to cross‐border infectious disease threat events in Europe. Transbound Emerg Dis, 66, 1855‑1863.

Talisuna A., Yahaya A.A., Rajatonirina S.C., Stephen M., Oke M., Mpairwe A., Diallo A.B., Musa E.O., Yota D., Mutoka Banza F., Wango R.K., Roberts N.A., Sreedharan R., Kandel N., Rashford A.M., Boulanger L.L., Huda Q., Chungong S., Zabulon Y. & Fall I.S. 2005. Joint external evaluation of the International Health Regulation (2005) capacities: current status and lessons learnt in the WHO African region. BMJ Glob Health, 4, e001312.

Tam T. 2018. Fifteen years post‑SARS: key milestones in Canada’s public health emergency response. Can Commun Dis Rep, 44, 98‑101.

Tellier R., Li Y., Cowling B.J. & Tang J.T. 2019. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis, 19, 101.

United Nations Office for Disaster Risk Reduction. 2020. Key concept: deterministic and probabilistic risk. ‑probabilistic‑risk (accessed on Jan 26, 2020).

World Health Assembly Resolution. 2014. Ebola virus disease outbreak and follow‑up to the special session of the executive board on Ebola. Adopted May 23, 2015.

World Health Organization (WHO). 2017. Strategic framework for emergency preparedness. Geneva: WHO, 2017.‑eng. pdf?sequence=1&isAllowed=y (accessed on Jan 27, 2020).

World Health Organization (WHO). 2018. IHR monitoring and evaluation framework. Geneva: WHO, 2018. WHO‑WHE‑CPI‑2018.51/en/ (accessed on Jan 25, 2020).

World Health Organization (WHO). 2018. IHR(IHR [2005]). Geneva: WHO, 2016.‑eng.pdf?sequence= (accessed on Jan 25, 2020).

World Health Organization (WHO). 2018. IHR monitoring and evaluation framework. Geneva: WHO, 2018.‑WHE‑CPI‑2018.51/en/ (accessed on Jan 25, 2020).

World Health Organization (WHO). 2019. WHO benchmarks for IHR (IHR) capacities. Geneva: WHO, 2019. (accessed on Jan 26, 2020).

World Health Organization (WHO). 2020. State party self‑assessment annual reporting tool. Geneva: WHO, Nov 19, 2018.‑WHE‑CPI‑2018.16/en/ (accessed on Jan 25, 2020).

World Health Organization (WHO). 2020. 2019 novel coronavirus (2019‑nCoV): strategic preparedness and response plan. Geneva: WHO, 2020.‑source/coronaviruse/srp04022020.pdf (accessed on Feb 24, 2020).

World Health Organization (WHO). 2020. Global health observatory ‑ international health regulations. Geneva: WHO, 2019. (accessed on Jan 25, 2020).

World Health Organization (WHO). 2020. IHR country capacity assessment, monitoring, evaluation and planning update. Geneva: World Health Organisation. (accessed on Feb 25, 2020).

World Health Organization (WHO). 2020. IHR States parties self‑assessment annual reporting (SPAR). Geneva: WHO, 2019. (accessed on Jan 25, 2020).

World Health Organization (WHO). 2020. Infection prevention and control during health care when novel coronavirus (NCoV) infection is suspected: interim guidance. Geneva: WHO, 2020.‑2019‑nCoV‑IPC‑v2020.1‑eng.pdf (accessed on Jan 26, 2020).

World Health Organization (WHO). Novel coronavirus (2019‑NCoV) situation report 1. Geneva: World Health Organisation, Jan 11, 2020.‑source/coronaviruse/situation‑reports/20200121‑sitrep1‑2019ncov.pdf?sfvrsn=20a99c10_4 (accessed on Jan 26, 2020).

World Health Organization (WHO). 2020. Novel coronavirus (2019‑NCoV) situation report 36. Geneva: WHO, Feb 25, 2020.‑source/coronaviruse/situation‑reports/20200225‑sitrep‑36‑covid‑19.pdf?sfvrsn=2791b4e0_2 (accessed on Feb 24, 2020).

World Health Organization (WHO). 2020. Risk communication and community engagement readiness and initial response for novel coronaviruses (NCoV). Jan 2020. Geneva: WHO, 2020.‑detail/risk‑communication‑and‑communityengagement‑readiness‑and‑initial‑response‑for‑novelcoronaviruses ‑(‑ncov) (accessed on Jan 26, 2020).

World Health Organization (WHO). 2020. WHO Director‑General’s statement on IHR Emergency Committee on Novel Coronavirus (2019‑nCoV). Geneva: WHO, Jan 30, 2020. detail/who‑director‑general‑s‑statement‑on‑ihr‑ emergencycommittee‑on‑novel‑coronavirus‑(2019‑ncov) (accessed on Jan 30, 2020).

World Health Organization (WHO). 2017. World Bank and WHO: half of the world lack access to essential health services, 100 million still pushed intro extreme poverty because of health expenses. Tokyo: WHO, Dec 13, 2017.‑room/ detail/13‑12‑2017‑world‑bank‑and‑who‑half‑the‑world‑lacks‑ access‑toessential‑health‑services‑100‑million‑still‑pushed‑into‑extremepoverty‑because‑of‑health‑expenses (accessed on Feb 5, 2020).

World Health Organization (WHO). 2019. Managing epidemics: key facts about major deadly diseases. Geneva: WHO, 2019.‑epidemics‑interactive.pdf (accessed Jan 26, 2020).

World Health Organization (WHO). 2019. Thematic paper on the status of country preparedness capacities. Geneva: WHO, 2019.‑2.pdf (accessed on Jan 25, 2020).

World Health Organization (WHO). 2020. Laboratory diagnostics for novel coronavirus. Geneva: WHO, 2020.‑diagnostics‑for‑novel‑coronavirus (accessed on Jan 26, 2020).

World Health Organization (WHO). 2005. Implementation of the IHR(2005): responding to public health emergencies: report by the director‑general.‑en.pdf. Published May 15, 2015 (accessed on May 26, 2015).World Health Organization (WHO). 2015. Proposed programme budget 2016‑2017.‑en.pdf. Published April 30, 2015 (accessed on May 27, 2015).

World Health Organization (WHO). 2015. Report of the Ebola interim assessment panel. Published July 2015.‑panel‑report/en/ (accessed on July 28, 2015).

Zhu N., Zhang D., Wang W., Na Z., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W., & China Novel Coronavirus Investigating and Research Team. 2019. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382, 727‑733.